D. Vena

Paclitaxel for platinum-refractory ovarian cancer: results from the first 1,000 patients registered to National Cancer Institute Treatment Referral Center 9103.

Edward L. Trimble, Jascha Adams, D. Vena et al. · Journal of Clinical Oncology · 1993 · 273 citations

Medicine, Oncology, Pharmacology +13

Second Malignancies as a Consequence of Nucleoside Analog Therapy for Chronic Lymphoid Leukemias

Bruce D. Cheson, D. Vena, Jane Barrett et al. · Journal of Clinical Oncology · 1999 · 219 citations

Medicine, Oncology, Pharmacology +16

Risk Factors for Osteonecrosis of the Jaws

Andrei Barasch, Joana Cunha‐Cruz, Francesca Currò et al. · Journal of Dental Research · 2011 · 211 citations · Full text

Dentistry, Oral Medicine, Oral Diagnosis +9

Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine via the Group C protocol mechanism of the National Cancer Institute: a report of 979 patients.

Bruce D. Cheson, John M. Sorensen, D. Vena et al. · Journal of Clinical Oncology · 1998 · 156 citations

Medicine, Oncology, Pharmacology +8

Preoperative and Postoperative Combination Chemotherapy for Potentially Resectable Gastric Carcinoma

Jaffer A. Ajani, R. John Mayer, David M. Ota et al. · JNCI Journal of the National Cancer Institute · 1993 · 121 citations

Medicine, Oncology, Surgery +13